a prospective randomized clinical trial was undertaken in 184 patients with metastatic breast carcinoma to compare single drug chemotherapy with l-phenylalanine mustard ( l-pam ) and intermittent combination chemotherapy with cyclophosphamide , methotrexate , and 5-fluourouracil ( cmf ) .
C0025677
methotrexate
C0950521
cmf